Global Oral Proteins and Peptides Market Set For Rapid Growth, To Reach USD 1671.8 Million By 2024

Zion Market Research has published a new report titled “Oral Proteins and Peptides Market by Drug Type (Linaclotide, Plecanatide, Calcitonin, Insulin, and Octreotide) and by Application (Gastric & Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2024”. According to the report, global oral proteins and peptides market was valued at approximately USD 772.4 million in 2017 and is expected to reach around USD 1671.8 million by 2024, growing at a CAGR of 12.3 % between 2018 and 2024.

The peptide and protein therapeutics are an important class of medicines, which are administered through the oral route to treat different diseases, which include hormonal, gastric, and metabolic disorders. These oral peptide and protein drugs hold a significant potential to improve the human health and are finding applications in the treatment of several diseases. The global oral peptide and protein market is driven by many key developments in the biopharmaceutical industry. First the presence of advanced analytical methods which are promoting rapid drug development and drug discovery. Advancement in the genetic engineering has enabled the large-scale commercial production of polypeptides previously available only in small quantities.

Browse the full "Oral Proteins and Peptides Market by Drug Type (Linaclotide, Plecanatide, Calcitonin, Insulin, and Octreotide) and by Application (Gastric & Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2024" report at https://www.zionmarketresearch.com/report/oral-proteins-and-peptides-market  

The primary factors responsible for the growth of oral proteins and peptides market are increasing the prevalence of chronic diseases, growing awareness regarding the benefits of oral peptides for the treatment of chronic diseases, and improving healthcare infrastructure in emerging economies. Oral peptide and proteins are used in many chronic diseases. Diabetes is one of the chronic diseases which is frequently treated by oral peptides and is expected to boost the growth of the global oral proteins and peptides market in the forecast period. As per the World Health Organization (WHO) estimates, the global prevalence of diabetes among adults has exponentially grown from 4.7% in 1980 to 8.5% in 2014. However, high capital requirements for drug development & drug discovery, contradictions regarding the efficacy and efficiency of oral peptides are restraining the growth of global oral proteins and peptides market. On the other hand, an untapped market, drugs under pipeline and clinical trials are expected to offer profitable opportunities for the key players in the forecast period.

By drug type, the global oral proteins and peptides market is divided into insulin, linaclotide, calcitonin, plecanatide, and octreotide. The insulin segment dominated the market and accounted for the largest share in 2017. Linaclotide was the fastest growing segment and is expected to grab a large share of total revenue in the coming years.

By application segment, the global oral proteins and peptides market is divided into diabetes, bone diseases, hormonal disorders, gastric & digestive disorders, and others. Diabetes was the leading application segment accounting the largest revenue share in 2017. The outsized share of diabetes segment is primarily accredited to the high acceptance of oral insulin in diabetic population and relative increase in the prevalence of diabetes. The bone disease segment is expected to grow at the highest CAGR during the forecast period.

Based on the geography, the global oral proteins and peptides market is divided into five regions North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to remain the dominant region over the forecast period. Europe was the second largest market followed by the Asia Pacific. Asia Pacific was the fastest growing market with the highest CAGR during the forecast period. Developing economies such as India and China accelerate the growth of this region owing to the development of healthcare infrastructure and heightened corporate investments in the healthcare sector. The Middle East and Africa and Latin America are expected to experience moderate growth in the oral proteins and peptides market in the years to come. 

Some of the key players in oral proteins and peptides market include Allergan Plc, Chiasma, Inc., Synthetic Biologics, Generex Biotechnology Corp., Proxima Concepts Limited (Diabetology Ltd.), Novo Nordisk A/S, and Tarsa Therapeutics Inc., Synergy Pharmaceuticals Inc., Sanofi S.A., Biocon Limited, F. Hoffmann-La Roche AG, AstraZeneca Plc, Inc., Hovione Limited, Novartis International AG, among others.

This report segments the global oral proteins and peptides market as follows:

Global Oral Proteins and Peptides Market: Drug Type Segment Analysis

• Integrated Software
• Linaclotide
• Plecanatide
• Calcitonin
• Insulin 
• Octreotide 

Global Oral Proteins and Peptides Market: Application Segment Analysis

• Gastric & Digestive Disorders
• Bone Diseases
• Diabetes 
• Hormonal Disorders
• Others

Global Oral Proteins and Peptides Market: Regional Segment Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com